The mast cell in inflammatory arthritis

New England Journal of Medicine

Volumn 348, Issue 17, 2003, Pages 1709-1711

  Woolley, David E ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; AUTOANTIBODY; COMPLEMENT; CORTICOSTEROID DERIVATIVE; CROMOGLYCATE DISODIUM; CYTOKINE; GROWTH FACTOR; HEPARIN; HISTAMINE; HISTIDINE DECARBOXYLASE; KETOTIFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROTEINASE; SALBUTAMOL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTHRITIS; ARTICLE; CHONDROLYSIS; CHONDROPATHY; DEGRANULATION; ENZYME SYNTHESIS; HUMORAL IMMUNITY; IN VIVO STUDY; INFLAMMATION; JOINT DESTRUCTION; MAST CELL; MEDIATOR; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIUM;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COMPLEMENT SYSTEM PROTEINS; HUMANS; MAST CELLS; MICE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037464519     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcibr023206     Document Type: Article

References (5)

1. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002;297:1689-92.
2. Tetlow LC, Woolley DE. Mast cells, cytokines and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 1995;54:896-903.
3. He S, Gaca MDA, Walls AF. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors. Eur J Pharmacol 2001;412:223-9.
4. Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2002;2:364-71.
5. Woolley DE, Tetlow LC. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res 2000;2:65-74.